Host genetic barriers to virus spillover
Host genetic barriers to virus spillover
批准号:
10310462
负责人:
Sara Sawyer
金额:
$41.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-01-10 至 2022-12-31
关键词:
AfricanAllelesAnimalsArenavirusAvian Influenza A VirusBiocompatible MaterialsBiological AssayCCR5 geneCD4 AntigensCanine ParvovirusCanis familiarisCell Surface ReceptorsCellsDataDengue VirusDiseaseEbola virusEpidemicEventEvolutionGeneticGenetic PolymorphismGenetic VariationGenotypeGoalsHIVHIV ReceptorsHousingHumanIndividualInfectionLentivirusMiddle East Respiratory Syndrome CoronavirusModelingMutationNatureOrthologous GenePlayPopulationPredispositionPrimate LentivirusesPrimatesProcessPropertyResearchRodentRoleSARS coronavirusSIVSurveysTestingVariantViralViral GenomeViral reservoirVirusWorkZika Virusbasecross-species transmissionexperimental studyfitnessinnovationnovelpet animalpreventreceptorsimian human immunodeficiency virusspillover eventtransmission process
中文摘要
项目摘要
病毒利用细胞表面受体进入宿主细胞内部。 这些受体现在
被认为是病毒传播的主要障碍,病毒传播是动物病毒从一个宿主物种传播的过程
变成另一个在许多有记录的溢出例子中,病毒通常在细胞中使用相同的进入受体。
新的和旧的宿主,但需要获得突变,使它们与特定的直系同源物兼容,
在新宿主中发现的受体。 多种病毒,如禽流感病毒、啮齿动物沙粒病毒、MERS
冠状病毒,可能还有SARS和埃博拉病毒,在传播时都克服了人类的受体屏障
从它们的动物宿主身上。 在这里,我们探讨了以下疾病出现的假设:病毒可以更多地
当特定受体基因型的宿主个体进入时,
contact.我们使用非洲灵长类动物的猴免疫缺陷病毒(SIV)库作为模型,
研究SIV/HIV受体CD 4和CCR 5在限制这些病毒溢出中的作用。灵长
慢病毒(SIV/HIV)是一个很好的模型,因为HIV/SIV受体CD 4和CCR 5是重要的
这些病毒在灵长类物种之间传播的宿主屏障。我们和其他人已经表明,(1)CD 4
和CCR 5在它们作为HIV/SIV受体的能力上从一个物种到下一个物种是不同的,和(2)不同的
由于受体多态性,灵长类种群中的个体具有不同的病毒易感性。
我们利用代表15个不同物种的大约1,300只灵长类动物的遗传数据和生物材料,
以及一系列不同的艾滋病病毒和SIV变异体,以验证人群中某些个体
更容易在疫情蔓延时传播或接受感染。提案的主要创新之处
是定义宿主遗传变异在疾病出现中的作用,而不仅仅是严格关注进化过程。
病毒的特性。 该项目将有助于我们理解导致人类进化的进化过程。
新疾病的出现。这是重要的,因为这里的工作将广泛适用于各种病毒
超越慢病毒,超越受体阻滞的宿主屏障。
英文摘要
Project Summary
Viruses exploit cell surface receptors to gain access to the interior of host cells. These receptors are now
appreciated as major obstacles to virus spillover, a process by which animal viruses move from one host species
into another. In the many documented examples of spillover, viruses typically use the same entry receptor in the
old and new host, but need to acquire mutations to make them compatible with the specific ortholog of that
receptor found in the new host. Diverse viruses such as avian influenza viruses, rodent arenaviruses, MERS
coronavirus, and possibly SARS and Ebola viruses all overcame receptor barriers in humans as they transmitted
from their animal hosts. Here, we explore the following hypothesis of disease emergence: viruses can more
easily overcome receptor barriers when host individuals of specific receptor genotypes come into
contact. We use the simian immunodeficiency virus (SIV) reservoir in African primates as a model for this, and
investigate the role that the SIV/HIV receptors, CD4 and CCR5, play in limiting spillover of these viruses. Primate
lentiviruses (SIV/HIV) are an excellent model because the HIV/SIV receptors CD4 and CCR5 serve as significant
host barriers to the spillover of these viruses between primate species. We and others have shown that (1) CD4
and CCR5 vary from one species to the next in their ability to serve as receptors for HIV/SIV, and (2) different
individuals within primate populations have different virus susceptibilities because of receptor polymorphisms.
We leverage genetic data and biomaterials from approximately 1,300 primates representing 15 different species,
and a broad array of different HIV and SIV variants, to test the idea that certain individuals within populations
are better poised to transmit or receive infection during spillover scenarios. The main innovation of the proposal
is to define the role of host genetic variation in disease emergence, beyond a strict focus on the evolutionary
properties of viruses. The project will aid in our understanding of the evolutionary processes leading to the
emergence of new diseases. It is significant because the work here will be widely applicable to diverse viruses
beyond lentiviruses, and to host barriers beyond receptor blocks.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/s12862-021-01783-z
发表时间:
2021-04-26
期刊:
BMC ecology and evolution
影响因子:
2.2
作者:
[Judd EN, Gilchrist AR, Meyerson NR, Sawyer SL]
通讯作者:
Sawyer SL
DOI:
10.1126/sciadv.abh2479
发表时间:
2021-06
期刊:
Science advances
影响因子:
13.6
作者:
[Burke JM, Gilchrist AR, Sawyer SL, Parker R]
通讯作者:
Parker R
DOI:
10.1016/j.cell.2022.08.002
发表时间:
2022-09-01
期刊:
CELL
影响因子:
64.5
作者:
[Rothenburg, Stefan, Yang, Zhilong, Beard, Pip, Sawyer, Sara L., Titanji, Boghuma, Gonsalves, Gregg, Kindrachuk, Jason]
通讯作者:
Kindrachuk, Jason
TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation.
DOI:
10.1016/j.celrep.2019.05.040
发表时间:
2019-06-11
期刊:
Cell reports
影响因子:
8.8
作者:
[Chiramel AI, Meyerson NR, McNally KL, Broeckel RM, Montoya VR, Méndez-Solís O, Robertson SJ, Sturdevant GL, Lubick KJ, Nair V, Youseff BH, Ireland RM, Bosio CM, Kim K, Luban J, Hirsch VM, Taylor RT, Bouamr F, Sawyer SL, Best SM]
通讯作者:
Best SM
DOI:
10.7554/elife.65113
发表时间:
2021-03-29
期刊:
eLife
影响因子:
7.7
作者:
[Yang Q, Meyerson NR, Clark SK, Paige CL, Fattor WT, Gilchrist AR, Barbachano-Guerrero A, Healy BG, Worden-Sapper ER, Wu SS, Muhlrad D, Decker CJ, Saldi TK, Lasda E, Gonzales P, Fink MR, Tat KL, Hager CR, Davis JC, Ozeroff CD, Brisson GR, McQueen MB, Leinwand LA, Parker R, Sawyer SL]
通讯作者:
Sawyer SL
共 12 条
Breaking the Barrier to an HIV Vaccine
-
批准号:10487962
-
项目类别:
-
资助金额:$109.55万
-
财政年份:2022
-
负责人:Sara Sawyer
-
依托单位:
Characterizing Host-Virus Interactions in a New HIV Model Organism
-
批准号:10676334
-
项目类别:
-
资助金额:$74.73万
-
财政年份:2022
-
负责人:Sara Sawyer
-
依托单位:
Characterizing Host-Virus Interactions in a New HIV Model Organism
-
批准号:10548703
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2022
-
负责人:Sara Sawyer
-
依托单位:
Breaking the Barrier to an HIV Vaccine
-
批准号:10708819
-
项目类别:
-
资助金额:$109.55万
-
财政年份:2022
-
负责人:Sara Sawyer
-
依托单位:
Hunting the HIV-1 Unicorn
-
批准号:10343694
-
项目类别:
-
资助金额:$92.4万
-
财政年份:2018
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:8122066
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:7865834
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:9187508
-
项目类别:
-
资助金额:$29.63万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:8247032
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:8039280
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:8448262
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:8638026
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
Rapid evolution of genes critical for genome integrity
-
批准号:9043108
-
项目类别:
-
资助金额:$17.32万
-
财政年份:2010
-
负责人:Sara Sawyer
-
依托单位:
海外基金